ArticleAnnals of medicine and surgery (2012)2026
A rare case of pulmonary sequestration with elevated CA19-9 levels.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Carbohydrate antigen 19-9 (CA19-9) is a tumor marker that is primarily linked to gastrointestinal cancer, especially to pancreatic cancer. Lung sequestration is a rare congenital anomaly, The link between them is not well-established. Case presentation: A 62-year-old male was found to have elevated CA19-9 levels, which were increased to 1524.93 U/ml. Despite this significant rise, the patient did not exhibit any notable symptoms. Imaging studies indicated the presence of left lung sequestration accompanied by infection and enlarged retroperitoneal lymph nodes, while further tests pointed towards a benign pancreatic lesion. A multidisciplinary team decided on surgical intervention, opting for a lobectomy. Following the surgery, the patient's CA19-9 levels decreased significantly, and after 3 months of follow-up, they returned to the normal range. Discussion: This case emphasizes the importance of recognizing elevated CA19-9 as a potential sign of underlying conditions, such as lung sequestration, and illustrates the effectiveness of surgical treatment in these scenarios. Conclusion: The findings highlight the necessity for comprehensive investigations in patients with unexplained elevations in CA19-9 to ensure prompt diagnosis and treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.